Indonesia joins with South Korea in COVID-19 vaccine push

30 July, 2020 | Source: Antara News

Indonesia is working with South Korea to develop a vaccine for the novel coronavirus disease, in addition to collaborating with China.

As part of the collaboration, Indonesia’s PT Kalbe Farma has joined with South Korea′s Genexine, which is currently conducting a phase 1 clinical trial of the COVID-19 vaccine in South Korea. The trial will end next August.

"While phase 2 clinical trials are planned to begin in Indonesia in September or October, 2020," Foreign Minister Retno Marsudi said in a virtual press conference from Jakarta on Thursday.

“(The collaboration of) Kalbe Farma with Genexine from South Korea (involves) using a (technological) platform for (the development of) DNA vaccine types," she continued.

According to Retno, the Indonesian Embassy and the Indonesian ambassador in Seoul have facilitated discussions between the two companies on the collaboration since last June.

Kalbe Farma and Genexine are still discussing cooperation on vaccine development, including the number of samples to be developed for the second phase of clinical trials and other arrangements.

In addition to South Korea, Indonesian company PT Bio Farma is also exploring opportunities for cooperation with the Coalition for Epidemic Preparedness Innovation (CEPI) for the development and production of vaccines.

"At present, Bio Farma has entered into the shortlist potential manufacturer for CEPI Covid-19 vaccine," Retno said.

CEPI is among the leading public-private partnership institutions for vaccine development. At least six COVID-19 vaccine candidates have been developed through the initiative, namely by Inovio, Moderna, AstraZeneca, CureVac, and Clover Biopharmaceuticals.

Foreign Minister Retno stressed that Indonesia would continue to intensify diplomatic efforts to help meet the requirement for vaccines, medical devices, and medicines for tackling the COVID-19 pandemic.

Earlier, on July 19, 2020, Bio Farma had received 2,400 COVID-19 vaccines from Sinovac for phase 3 clinical trials in Indonesia.

Candidates for the vaccine developed by the Chinese company will be clinically tested from August, 2020 and the trial is targeted for completion in January, 2021.

 

Indonesia is working with South Korea to develop a vaccine for the novel coronavirus disease, in addition to collaborating with China.
Indonesia′s economy will start to open and recover from the COVID-19 crisis in August this year, the World Bank′s Country Director for Indonesia, Satu Kahkonen, stated on Thursday.
PT Medco Energi Internasional (MedcoEnergi) reported first gas production from Meliwis Field on July 13 in its working area in Madura offshore, East Java, four years since the field’s discovery in Mundu Formation in 2016.
The Government of Indonesia praised its Serbian counterpart for its help in extraditing Maria Pauline Lumowa, a fugitive 17 years since being named a suspect, over Bank Negara Indonesia′s (BNI′s) US$136-million fraud case.
Toba Caldera was inscribed on the List of UNESCO Global Geoparks (UGGp) at the 209th Session of the UNESCO Executive Board held in Paris, France, on Tuesday (July 2).
The Indonesian government, through a resolution issued by the Ministry of Health, has officially enforced health protocols for the tourism and creative economy sector.
Address: 1068 Budapest, Városligeti fasor 26. | MAP |
Phone: (+36-1) 413 3800 Fax: (+36-1) 322 8669
E-mail: embassy@indonesianembassy.hu